EP Biocomposites Limited (BOM:543595)
125.45
+2.45 (1.99%)
At close: Apr 23, 2025
EP Biocomposites Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | 13.22 | 12.7 | 21.92 | 1.56 | 1.48 | 1.16 |
Cash & Short-Term Investments | 13.22 | 12.7 | 21.92 | 1.56 | 1.48 | 1.16 |
Cash Growth | -27.98% | -42.05% | 1304.94% | 5.48% | 27.83% | - |
Accounts Receivable | 97.25 | 89.98 | 58.61 | 70.96 | 6.47 | 3.02 |
Other Receivables | - | 1.65 | - | 0.78 | - | - |
Receivables | 97.25 | 91.62 | 58.61 | 71.74 | 6.49 | 3.04 |
Inventory | 14.05 | 10.35 | 10.16 | 11.83 | 4.5 | 1.11 |
Other Current Assets | 6.84 | 10.24 | 1.93 | 0.64 | 0.56 | 0.21 |
Total Current Assets | 131.35 | 124.92 | 92.62 | 85.77 | 13.03 | 5.52 |
Property, Plant & Equipment | 3.6 | 3.78 | 2.02 | 2.37 | 0.02 | - |
Other Intangible Assets | 0.7 | 0.9 | 1.32 | 1.73 | - | - |
Long-Term Deferred Tax Assets | 0.13 | 0.08 | 0.01 | - | - | - |
Long-Term Deferred Charges | - | - | - | 2.22 | - | - |
Other Long-Term Assets | 21.04 | 21.05 | 21.28 | 0.67 | 0.18 | - |
Total Assets | 156.81 | 150.73 | 117.24 | 92.77 | 13.24 | 5.52 |
Accounts Payable | 19.47 | 29.37 | 11.85 | 21.97 | 6.44 | 4.64 |
Accrued Expenses | - | 0.45 | 2.06 | 1.13 | 0.51 | 0.08 |
Short-Term Debt | 22.02 | 6.98 | - | 18.7 | - | - |
Current Portion of Long-Term Debt | - | - | 0.81 | 0.66 | - | - |
Current Income Taxes Payable | - | 4.25 | 2.22 | 3.17 | 1.18 | 0.12 |
Other Current Liabilities | 3.91 | 2.99 | 3.87 | 4 | 1.24 | 0.38 |
Total Current Liabilities | 45.39 | 44.05 | 20.81 | 49.63 | 9.37 | 5.21 |
Long-Term Debt | 13.72 | 11.04 | 12.01 | 21.75 | - | 0.03 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.05 | - | - |
Total Liabilities | 59.12 | 55.09 | 33.1 | 72.79 | 9.37 | 5.23 |
Common Stock | 16.82 | 16.82 | 16.82 | 11.78 | 0.5 | 0.5 |
Additional Paid-In Capital | - | 53.36 | 53.36 | - | - | - |
Retained Earnings | - | 25.47 | 13.97 | 8.21 | 3.37 | -0.21 |
Shareholders' Equity | 97.7 | 95.64 | 84.14 | 19.98 | 3.87 | 0.29 |
Total Liabilities & Equity | 156.81 | 150.73 | 117.24 | 92.77 | 13.24 | 5.52 |
Total Debt | 35.74 | 18.02 | 12.82 | 41.11 | - | 0.03 |
Net Cash (Debt) | -22.52 | -5.32 | 9.1 | -39.55 | 1.48 | 1.13 |
Net Cash Growth | - | - | - | - | 30.65% | - |
Net Cash Per Share | -13.36 | -3.16 | 6.23 | -46.35 | 3.94 | - |
Filing Date Shares Outstanding | 1.68 | 1.68 | 1.68 | 1.17 | 0.38 | - |
Total Common Shares Outstanding | 1.68 | 1.68 | 1.68 | 1.17 | 0.38 | - |
Working Capital | 85.96 | 80.87 | 71.81 | 36.14 | 3.66 | 0.31 |
Book Value Per Share | 58.00 | 56.88 | 50.04 | 17.08 | 10.31 | - |
Tangible Book Value | 97 | 94.74 | 82.83 | 18.25 | 3.87 | 0.29 |
Tangible Book Value Per Share | 57.59 | 56.34 | 49.26 | 15.60 | 10.31 | - |
Machinery | - | 3.93 | 2.92 | - | 0.03 | - |
Construction In Progress | - | 1.35 | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.